Landscape Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Landscape Capital Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-163,100	Closed	-$512K	–	682
2016 Q2	$512K	Sell	163,100 -99,000	-38%	-$330K	0.07%	330
2016 Q1	$873K	Buy	262,100 +142,900	+120%	+$445K	0.11%	293
2015 Q4	$422K	Buy	119,200 +29,541	+33%	+$124K	0.05%	561
2015 Q3	$451K	Buy	89,659 +15,059	+20%	+$86.3K	0.06%	358
2015 Q2	$480K	Buy	74,600 +3,019	+4%	+$20.2K	0.08%	365
2015 Q1	$504K	Buy	+71,581	New	+$518K	0.13%	213
2014 Q4	–	Sell	-15,000	Closed	-$112K	–	674
2014 Q3	$112K	Sell	15,000 -2,200	-13%	-$20.4K	0.08%	334
2014 Q2	$166K	Buy	+17,200	New	+$153K	0.11%	258

Other funds holding PDLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Landscape Capital Management's PDLI Position: Q3 2016 in Review

Landscape Capital Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2016, closing a stake of 163,100 shares — an estimated $512K sold.

Landscape Capital Management first reported a position in PDLI in Q2 2014 and held it in 8 quarters. The position peaked at $873K in Q1 2016. 197 funds tracked by Wall St. Rank hold PDLI as of Q3 2016.

Landscape Capital Management reported no remaining PDL BioPharma, Inc. position as of Q3 2016 after selling out during the quarter.
Landscape Capital Management sold 163,100 PDL BioPharma, Inc. shares in Q3 2016, an estimated $512K.
Landscape Capital Management first reported a position in PDL BioPharma, Inc. in Q2 2014 and held it in 8 quarters.
Landscape Capital Management's PDL BioPharma, Inc. position peaked at $873K in Q1 2016.
197 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2016.

Based on Landscape Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.